Literature DB >> 731266

Experimental (-) emetine myopathy. Ultrastructural and morphometric observations.

L Bindoff, M J Cullen.   

Abstract

The ultrastructural changes induced by (-) emetine hydrochloride were studied in two skeletal muscles of the rat. (-) Emetine was administered at a dose level of 2 mg/kg for periods ranging from one to four weeks. Changes were noted after the one week stage and were progressive with all muscle components appearing to be affected. Myofibrillar changes included Z line streaming, rod formation, myofilament loss and contraction clumping. Mitochondrial degeneration was detected, but the most striking feature of the induced myopathy was the extensive membrane proliferation. The membranes were considered to be involved in the isolation of sarcoplasmic constitutents in the production of autophagic vacuoles. Morphometry was carried out in order to quantify some of the changes in the fibre components.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731266     DOI: 10.1016/0022-510x(78)90183-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Myopathy from surreptitious ipecac ingestion.

Authors:  N L Rosenberg; S P Ringel
Journal:  West J Med       Date:  1986-09

2.  Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.

Authors:  P K Panegyres; J M Papadimitriou; P N Hollingsworth; J A Armstrong; B A Kakulas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

Review 3.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

4.  Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies.

Authors:  N J Hopf; H H Goebel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Ipecac myopathy and cardiomyopathy.

Authors:  L P Dresser; E W Massey; E E Johnson; E Bossen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

7.  Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.

Authors:  T Kuntzer; J Bogousslavsky; J P Deruaz; R Janzer; F Regli
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

8.  A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy.

Authors:  Salvo Danilo Lombardo; Maria Sofia Basile; Rosella Ciurleo; Alessia Bramanti; Antonio Arcidiacono; Katia Mangano; Placido Bramanti; Ferdinando Nicoletti; Paolo Fagone
Journal:  Genes (Basel)       Date:  2021-04-09       Impact factor: 4.096

9.  Lead Optimization of Dehydroemetine for Repositioned Use in Malaria.

Authors:  Priyanka Panwar; Kepa K Burusco; Muna Abubaker; Holly Matthews; Andrey Gutnov; Elena Fernández-Álvaro; Richard A Bryce; James Wilkinson; Niroshini Nirmalan
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.